Insider · CIK 0001554661

Evans Johnston L

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001554661

Forms 4 and 5

Insider transactions

35 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2015-05-04	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+3,086 sh	—	—	3,086
2014-11-09	XENEXenon Pharmaceuticals Inc.C Conversion	Director	CConversion	+445K sh	—	—	444,655
2014-11-09	XENEXenon Pharmaceuticals Inc. · Series E Preferred SharesC Conversion	Director	CConversion	−445K sh	—	—	0
2014-11-04	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,144 sh	—	—	5,144
2013-08-15	E2open IncS Sale	Director	SSale	−1,879 sh	$20.10	−$37.8K	774,853
2013-08-15	E2open IncS Sale	Director	SSale	−968 sh	$20.10	−$19.5K	399,451
2013-08-15	E2open IncS Sale	Director	SSale	−293 sh	$20.10	−$5,889.3	121,056
2013-08-13	E2open IncS Sale	Director	SSale	−947 sh	$19.80	−$18.7K	400,481
2013-08-13	E2open IncS Sale	Director	SSale	−1,838 sh	$19.80	−$36.4K	776,851
2013-08-13	E2open IncS Sale	Director	SSale	−119 sh	$20.10	−$2,391.9	776,732
2013-08-13	E2open IncS Sale	Director	SSale	−62 sh	$20.10	−$1,246.2	400,419
2013-08-13	E2open IncS Sale	Director	SSale	−287 sh	$19.80	−$5,682.342	121,368
2013-08-13	E2open IncS Sale	Director	SSale	−19 sh	$20.10	−$381.9	121,349
2013-08-12	E2open IncS Sale	Director	SSale	−1,115 sh	$19.71	−$22K	121,655
2013-08-12	E2open IncS Sale	Director	SSale	−3,679 sh	$19.71	−$72.5K	401,428
2013-08-12	E2open IncS Sale	Director	SSale	−2,929 sh	$19.71	−$57.7K	405,107
2013-08-12	E2open IncS Sale	Director	SSale	−888 sh	$19.71	−$17.5K	122,770
2013-08-12	E2open IncS Sale	Director	SSale	−5,683 sh	$19.71	−$112K	785,823
2013-08-12	E2open IncS Sale	Director	SSale	−7,134 sh	$19.71	−$141K	778,689
2013-08-08	E2open IncS Sale	Director	SSale	−299 sh	$19.72	−$5,896.878	791,506
2013-08-08	E2open IncS Sale	Director	SSale	−47 sh	$19.72	−$926.934	123,658
2013-08-08	E2open IncS Sale	Director	SSale	−154 sh	$19.72	−$3,037.188	408,036
2013-04-03	E2open IncStock Option (right to buy)A Award	Director	AAward	+11.8K sh	—	—	11,800
2012-07-31	E2open IncSeries D Convertible Preferred StockC Conversion	Director	CConversion	−261K sh	—	—	0
2012-07-31	E2open IncSeries BB Convertible Preferred StockC Conversion	Director	CConversion	−181K sh	—	—	0
2012-07-31	E2open IncC Conversion	Director	CConversion	+408K sh	—	—	408,190
2012-07-31	E2open IncSeries D Convertible Preferred StockC Conversion	Director	CConversion	−135K sh	—	—	0
2012-07-31	E2open IncSeries BB Convertible Preferred StockC Conversion	Director	CConversion	−54.8K sh	—	—	0
2012-07-31	E2open IncSeries CC Convertible Preferred StockC Conversion	Director	CConversion	−15.1K sh	—	—	0
2012-07-31	E2open IncSeries D Convertible Preferred StockC Conversion	Director	CConversion	−40.8K sh	—	—	0
2012-07-31	E2open IncC Conversion	Director	CConversion	+792K sh	—	—	791,805
2012-07-31	E2open IncSeries CC Convertible Preferred StockC Conversion	Director	CConversion	−49.9K sh	—	—	0
2012-07-31	E2open IncC Conversion	Director	CConversion	+124K sh	—	—	123,705
2012-07-31	E2open IncSeries BB Convertible Preferred StockC Conversion	Director	CConversion	−351K sh	—	—	0
2012-07-31	E2open IncSeries CC Convertible Preferred StockC Conversion	Director	CConversion	−96.8K sh	—	—	0

Recent filings

Accepted (ET)
May 64
Xenon Pharmaceuticals Inc.0001171843-15-002563
SEC(opens sec.gov)
Nov 124
Xenon Pharmaceuticals Inc.0001209191-14-068354
SEC(opens sec.gov)
Nov 64
Xenon Pharmaceuticals Inc.0001209191-14-067026
SEC(opens sec.gov)
Aug 194
E2open Inc0001209191-13-041320
SEC(opens sec.gov)
Aug 144
E2open Inc0001209191-13-040739
SEC(opens sec.gov)
Aug 124
E2open Inc0001209191-13-040281
SEC(opens sec.gov)

Companies

Address

C/O INVESCO PRIVATE CAPITAL, INC. 1166 AVENUE OF THE AMERICAS, 25TH FLOOR

NEW YORK, NY, 10036